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Abstract: PURPOSE Childhood cancer and its treatment may affect health-related quality of life
(HRQoL) in childhood cancer survivors, but population-based studies in young survivors are scarce.
We aimed to: (1) compare HRQoL between young survivors and population norms and (2) find factors
that influence parent-reported HRQoL in survivors. METHODS As part of the Swiss Childhood Cancer
Survivor Study, a questionnaire was mailed to parents of survivors aged 8-16 years, registered in the
Swiss Childhood Cancer Registry, ￿5 years after diagnosis. We used the KIDSCREEN-27 instrument
to compare self- and parent-reported HRQoL between survivors (N = 425) and standardized norms in
the five dimensions of physical well-being, psychological well-being, autonomy, peers and school envi-
ronment (mean = 50, SD = 10). We then used multivariable linear regressions to test the influence
of socio-demographic and cancer-related factors on HRQoL. RESULTS Self-reported physical well-being
was comparable to norms. Other HRQoL dimensions were higher than norms, with the highest mean
= 52.2 (p < 0.001) for school environment. Parent-reported HRQoL in survivors was comparable to
population norms; only physical well-being was lower (mean = 47.1, p < 0.001), and school environment
was higher (mean = 51.1, p = 0.035). Parent-reported HRQoL was lower for survivors of CNS tumors
(physical well-being: ￿ = -5.27, p = 0.007; psychological well-being: ￿ = -4.39, p = 0.044; peers ￿ = -5.17,
p = 0.028), survivors of neuroblastoma (psychological well-being ￿ = -5.20, p = 0.047), and survivors
who had had a relapse (physical well-being ￿ = -5.41, p = 0.005). CONCLUSIONS Assessing HRQoL
during follow-up care, with a focus on physical well-being, specific diagnoses (e.g., CNS tumor) and late
complications (e.g., relapse) might help to early identify problems and offer support to survivors with
reduced HRQoL.
DOI: 10.1007/s11136-015-0961-3
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Janine Vetsch, MSc,1 Corina S. Rueegg, PhD,1 Mico`l E. Gianinazzi, PhD,1 Eva Bergstra¨sser, MD,4
Nicolas X. von der Weid, MD,2 Gisela Michel, PhD,1,3* and for the Swiss Paediatric Oncology Group (SPOG)
INTRODUCTION
Childhood cancer survivors are at considerable risk of late
effects [1], requiring their parents to be informed about
recommended follow-up care or screening in order to make
appropriate decisions and give support to their child [2]. Parents’
knowledge about diagnosis, treatment administered, appropriate
long-term care plan and risk for late effects is important to
understand the disease and provide reassurance. Parents are the
child’s guardian because the child is often very young at diagnosis.
They therefore play a central role in subsequently transferring
knowledge and information to their child and thus empowering
participation in follow-up care [3].
Adequate information for parents of chronically ill children
is not only important for knowledge transfer to their child but
also for parents themselves to feel reassured and less worried [4].
Many parents of children with cancer desire an “end of
treatment meeting” [5], which could help to reduce their
concerns about recurrence, and treatment late effects and inform
them about appropriate follow-up care recommendations. A
review on communication practices in other chronic diseases
concluded that parental stress and anxiety can be reduced with
improved education and communication to parents in newborn
screening programs [6].
A recent study among parents of childhood cancer patients
shortly after diagnosis showed their satisfaction with information
on current disease and treatment, but they also reported a lack of
information about the future [7]. This lack of information might
increase with time after diagnosis and fewer health care visits
during follow-up. Another study showed that shortly after the end of
treatment survivors are generally satisfied with the information
received [8]. However, parents were interested in receiving
additional information on various topics such as how to prepare
for and cope with the end of treatment. A recent Dutch study found
that even after a visit to an outpatient clinic, both cancer survivors
and their parents still had information needs on late effects and
Background. Parents’ knowledge about cancer, treatment,
potential late effects and necessary follow-up is important to reassure
themselves and motivate their child to participate in regular follow-
up. We aimed to describe (i) parents’ perception of information
received during and after treatment; (ii) parents’ current needs for
information today, and to investigate; and (iii) associations between
information needs and socio-demographic and clinical character-
istics. Methods. As part of the Swiss Childhood Cancer Survivor
Study, a follow-up questionnaire was sent to parents of survivors,
diagnosed<16 years and after 1990, and aged 11–17 years at study.
We assessed parents’ perception of information received and
information needs, concerns about consequences of the cancer
and socio-demographic information. Information on clinical data
was available from the Swiss Childhood Cancer Registry. Results. Of
309 eligible parents, 189 responded (67%; mean time since
diagnosis: 11.3 years, SD¼2.5). Parents perceived to have received
verbal information (on illness: verbal 91%, written 40%; treatment:
verbal 88%, written 46%; follow-up: verbal 85% written 27%; late
effects: verbal 75%, written 19%). Many parents reported current
information needs, especially on late effects (71%). The preferred
source was written general (28%) or verbal information (25%), less
favored was online information (12%). Information needs were
associated with migration background (P¼0.039), greater concerns
about consequences of cancer (P¼0.024) and no information
received (P¼0.035). Conclusion. Parents reported that they received
mainly verbal information. However, they still needed further
information especially about possible late effects. Individual long-
term follow-up plans, including a treatment summary, should be
provided to each survivor, preferably in written format. Pediatr Blood
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authors suggested that they might profit from an online
platform [9,10]. A study from our group on long-term childhood
cancer survivors showed that survivors desired to be better informed
especially on potential late effects, and wished to receive
personalized information [11].
The literature so far included mainly studies performed shortly
after treatment [5,8,12] or focused on information needs of
survivors and rarely of the parents [9–11]. We therefore aimed to
(i) describe the information parents remembered to have received
during and after their child’s cancer treatment; (ii) investigate
parents’ needs for information today many years after diagnosis;
and (iii) investigate the association between information needs and
(1) parents’ socio-demographic characteristics and (2) clinical
characteristics of the child’s disease.
METHODS
Sample and Procedure
The Swiss Childhood Cancer Registry (SCCR) is a popula-
tion-based registry including all cancer patients younger than
21 years and Swiss residents at diagnosis who were diagnosed
with leukemia, lymphoma, CNS tumor, malignant solid tumor or
Langerhans cell histiocytosis [13,14]. The Swiss Childhood
Cancer Survivor Study (SCCSS) is a nationwide, long-term
survey including a baseline (years 2007–2011) and a follow-up
questionnaire (years 2010–2012). The baseline questionnaire
included all patients registered in the SCCR who survived at least
5 years and were diagnosed between 1976–2005, aged < 16
years [15]. Parents of survivors were contacted if survivors were
aged 5–15 years at the time of study. As part of the follow-up
survey, parents were contacted again. They were included if they
had previously completed the baseline questionnaire, their child
or adolescence who survived cancer was aged 11–17 years at
study and diagnosed after 1990 (N¼ 306; Supplemental Figure 1).
Some survivors were already aged 18 years by the time the
questionnaire was completed by parents.
Among eligible parents, the mother or father who completed
the baseline questionnaire was contacted and received a further
questionnaire with a different focus and a prepaid return
envelope. If they did not reply within 2 months, non-responders
received the questionnaire a second time with a reminder letter
and another prepaid return envelope. Questionnaires were
available in German and French. Ethics approval was provided
through the general cancer registry permission of the SCCR (The
Swiss Federal Commission of Experts for Professional Secrecy in
Medical Research). Additionally, we received a non-obstat
statement from the ethics committee of the canton of Bern




Parents could indicate whether they remembered having
received information from a medical doctor on illness,
treatment, follow-up and late effects (perceived of information
received: ever/never). For each domain, they could specify the
information format: verbal and/or written information, or no
information.
Information Needs
Parents could indicate their current information needs in the
following domains: illness, treatment, follow-up and late effects
(yes/no?). They were asked for each domain to describe the
preferred format: (i) verbal; (ii) general written; (iii) personal
written; (iv) general online information; or (v) if no information was
desired.
Explanatory Variables Assessed by Questionnaire of
Parents
We assessed parents’ gender, age at study, migration back-
ground, language region, parents’ education and employment
status, their involvement in follow-up care of their child and
concerns about the consequences of the child’s cancer. Parents’ age
at study was divided in two categories:  45 years and > 45 years.
Parents were classified as having a migration background if they
were not Swiss citizens since birth or not born in Switzerland.
Language region was divided into German and French. Parents’
education was divided into three categories: primary (compulsory
schooling, vocational training); secondary (including teachers,
technical, commercial schools etc. and university of applied
sciences); tertiary (university) [16]. Employment status was coded
as employed (yes/no). Parents were asked whether they were
involved in follow-up care of their child (yes/no). Concerns of
parents about consequences of their child’s illness were assessed by
the question “How concerned are you about consequences of your
child’s illness?” This is an adapted question from the Brief Illness
Perception Questionnaire (IPQ) using a 0-to-10 response scale [17].
Items were scored as 0–2¼ no concern, 3–6¼medium concerns
and 7–10¼ high concerns. Throughout the manuscript, this
expression will be used as “consequences of cancer.” From the
baseline questionnaire of the SCCSS, we extracted information
about child late effects (yes/no) [15].
Child Clinical Variables Extracted From the SCCR
We extracted medical information on diagnosis and treatment of
the child from the Swiss Childhood Cancer Registry: cancer
diagnosis, cancer treatment, type of treating hospital, age at
diagnosis, time since diagnosis and relapse.
We classified diagnosis according to the International Classifi-
cation of Childhood Cancer-3rd Edition [18]. For the regression
model, we grouped diagnosis into three categories: leukemia/
lymphoma, tumors of the central nervous system (CNS) and other
tumors. Treatment was coded as: chemotherapy (without radio-
therapy but possibly with surgery), surgery only, radiotherapy (with
surgery or chemotherapy), and stem cell transplantation (SCT). The
type of treating hospital was divided into university and regional
hospital. Age at diagnosis was divided into three age categories: 0–1
year, 2–4 years and  5 years. Time since diagnosis was divided
into two categories: 5–10 years and 10 years. Relapse was coded
yes or no.
Analyses
Analyses were conducted using STATA 13.1. First, we describe
the study population and differences between participants and non-
participants, using proportions, means, chi square statistics and
paired t-tests. For aims 1 and 2, we summarize proportions with
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95% confidence intervals (CI) of parents reporting they received
information and their information needs, respectively for the four
domains illness, treatment, follow-up and late effects. We describe
the type of information they remember to have received and what
type of information they would now want. For the descriptive
analysis, each domain and format were analyzed separately. For the
analytic analysis, we additionally created an overall binary variable:
information received (if either verbal or written information was
perceived to be received in all four domains) versus no information
received (if no information was received in any of the four
domains). Additionally, we created a binary variable for each
domain of information needs: information needs (if needs were
present in at least one format in the respective domain) versus no
information needs (no information was desired). For aim 3, we used
univariable logistic regression models to analyze associations of
socio-demographic characteristics of the parents and clinical
factors of the child with information needs. For the analysis, an
overall binary variable was created: parents were categorized as
having information needs if they reported a need in any of the four
domains and as having no needs if they reported no information
needs in all four domains. Given the small number of participants
we could not perform a multivariable logistic regression model.
RESULTS
Study Population
Of the 306 eligible parents, we traced and contacted 284
(Supplemental Figure 2). Of those, 189 (67%) responded. The mean
age of the parents was 46.1 years (SD¼ 4.8, range 33.5–59.5 years),
mean time since diagnosis 11.3 years (SD¼ 2.5, range 6.8–17.2)
and mean age of the child at study completion was 14.7 years
(SD¼ 1.8, range 10.7–18.0 years; Table I). Most children were
diagnosed with leukemia (39.2%), followed by CNS tumors
(18.0%) and lymphomas (8.5%). There was no difference between
participating and non-participating parents regarding language
region of Switzerland, cancer type, treatment received, type of
treating hospital, child’s age at diagnosis, time since diagnosis,
relapse status and parent-reported late effects.
Perception of Information Received on Illness,
Treatment, Follow-Up and Late Effects
Most parents reported they received information and only a few
parents reported not having received any information on one of the
domains (Figure 1). Most of the parents who received information
had received verbal information (74.6–91.0%). Fewer parents had
received written information on illness (39.6%, CI 32.6–46.7%) and
treatment (45.5%, CI 38.3–52.7%), and even fewer on follow-up
(27.0%, CI 20.6–33.4%) and late effects (19.0%, CI 13.4–24.7%).
Of those parents who did not receive information, five (2.6%)
reported they received no information on illness, three (1.5%) on
treatment, 11 (5.8%) on follow-up and 32 (16.9%) on late effects.
Only one parent reported not having received any information on
any domain.
Reported Information Needs on Illness, Treatment,
Follow-Up and Late Effects
Overall, about half of the parents reported information needs on
illness (49.4%, CI 42.0–56.9%), treatment (48.8%, CI 41.3–56.4%)
and follow-up (56.6%, CI 49.2–64.0%) irrespective of the format
(Figure 2). In contrast, 70.9% (CI 64.0–77.7%) reported informa-
tion needs on late effects. Across all domains, 45 (23.8%) parents
reported no needs in any format. Having or not having information
needs was independent of the information received and the format
of the information received (written or verbal; Supplemental
Table I). Most parents who did not receive any information reported
current information needs.
The format most frequently chosen was written general (17.5–
27.5%) or verbal (15.9–24.9%) (Figure 3). The format chosen by
fewest parents was online information (5.3–12.2%).
Factors Associated With Information Needs
In univariable regression models, parents reporting overall
information needs were more likely to have a migration background
(OR 5.55, CI 0.71–43.2, P¼ 0.039), report concerns about
consequences of cancer (medium: OR 2.50; CI 1.04–6.04; high:
OR 2.95, CI 1.3–6.68, global p for concerns¼ 0.024) and did not
receive all the information (OR 2.95, CI 0.97–8.90, P¼ 0.035;
Table II).
Parents reporting information needs on illness were more likely
to report greater concerns about consequences of cancer (medium:
OR¼ 2.42, CI 1.07–5.48, high: OR¼ 2.84, CI 1.34–6.0; global p
for concerns¼ 0.017; Supplemental Table II). Parents reporting
information needs on treatment were more likely to have a child
diagnosed with CNS tumor (OR¼ 2.88, CI 1.12–6.71) or other
tumors (OR¼ 1.44, CI 0.73–2.83; global p for diagnosis¼ 0.043)
and to report greater concerns about consequences of cancer
(medium: OR¼ 2.04, CI 0.91–4.58; high: OR¼ 2.47, CI 1.17–5.21,
global p for concerns¼ 0.050). Parents reporting information needs
on follow-up were more likely to be involved in follow-up care
(OR¼ 2.1, CI 0.99–4.43, P¼ 0.049) and to report greater concerns
about consequences of cancer (medium: OR¼ 2.42, CI 1.07–5.47;
high: OR¼ 3.16, CI 1.49–6.72, global p for concerns¼ 0.008).
Parents reporting information needs on late effects were more likely
to report late effects (OR¼ 2.95, CI 1.29–4.88, P¼ 0.016), greater
concerns about consequences of cancer (medium: OR¼ 2.11, CI
0.91–4.88, high: OR¼ 3.06, CI 1.37–6.84; global p for concerns
¼ 0.019) and did not receive all the information (OR¼ 2.62, CI
0.95–7.24, P¼ 0.045).
DISCUSSION
A large proportion of parents reported that they received verbal
information on illness, treatment and follow-up. While one fifth
reported not having received information on late effects, more than
half of parents desired more information in a written general or
verbal personal way especially about late effects. Information
provision through online sources was not highly favored. Most
parents who reported no information needs had received informa-
tion either verbally or written; however, there was no difference
whether the information was received only verbally or both verbally
and written. Information needs were more often reported by parents
with a migration background, with greater concerns about
consequences of cancer and who had not received all the
information before.
A major strength of this study is the population-based sample of
parents of childhood cancer survivors with prospectively collected
data on clinical variables from the Swiss Childhood Cancer
Pediatr Blood Cancer DOI 10.1002/pbc
Parental Information Needs and Cancer Survivorship 3
TABLE I. Characteristics of the Study Population, Comparing Participants and Non-Participants
Participants Non-participantsa
N %c N %c P-valueb
Total 189 100 117 100
Sociodemographic characteristics of parent responder
Sex
Female 160 84.7 n.a.d
Male 29 15.3 n.a.
Age at study
45 years 89 47.1 n.a.
>45years 92 48.7 n.a.
unknown 8 4.2 n.a.
Migration background
Swiss 172 91.0 n.a.
Immigrant 17 9.0 n.a.
Language region 0.516
German 132 70.2 78 66.7
French 56 29.8 39 33.3
Education
Primary 101 54.3 n.a.
Secondary 62 33.3 n.a.
Tertiary 23 12.4 n.a.
Employment
Employed 150 79.4 n.a.
Unemployed 39 20.6 n.a.
Clinical characteristics of the child
Diagnosis 0.511
Leukemia 74 39.2 46 39.3
Lymphomas 16 8.5 10 8.5
CNS tumors 34 18.0 23 19.7
Neuroblastoma 13 6.9 8 6.8
Retinoblastoma 13 6.9 5 4.3
Renal tumors 12 6.3 8 6.8
Hepatic tumors 4 2.1 3 2.6
Malignant tumors 2 1.1 3 2.6
Soft tissue sarcomas 14 7.4 3 2.6
Germ cell tumors 2 1.1 3 2.6
LCH 2 1.1 3 2.6
Othere 3 1.6 0 0.0
Treatment receivedf 0.793
Surgery only 30 16.0 20 17.5
Chemotherapy 118 63.1 74 64.9
Radiotherapy 30 16.0 17 14.9
SCT 9 4.9 3 2.6
Type of treating hospital 0.541
University hospital 160 84.7 102 87.2
Regional hospital 29 15.3 15 12.8
Child’s age at diagnosis 0.831
0-1 years 58 30.7 35 29.9
2-4 years 82 43.4 48 41.0
5þ years 49 25.9 34 29.1
Time since diagnosis 0.803
5-10 years 64 33.9 38 32.5
10þ years 125 66.1 79 67.5
Relapse 1.000
No 168 88.9 104 88.9
Yes 21 11.1 13 11.1
Parent-reported late effects 0.103
No 100 54.4 68 64.2
Yes 84 45.6 38 35.8
Parents involvement in follow-up care
No 40 78.3 n.a.
Yes 144 21.7 n.a.
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Registry and data from the follow-up questionnaires from the Swiss
Childhood Cancer Survivor Study. Furthermore, the response rate
was good (67%). A limitation might be self-selection because
parents of specific groups may have been more reluctant to
complete the questionnaire, especially after having filled in the
baseline questionnaire. Other parents might have been excluded
because they were not interested in the baseline questionnaire.
Another limitation might be that only one parent was contacted and
therefore only one questionnaire was filled in per family. Answers
might differ between fathers and mothers and it is not known if
questionnaires were completed together or alone. When assessing
the information a person reported to have received, we have to take
into account that the person might have received it, but did not
understand it, forgot it or that the information might not have been
given to the parents but to the survivors themselves even though
they were quite young at diagnosis. In addition, the need for more
information differs from person to person and this subjective need
may influence our results. Due to the sample size, only a few results
were statistically significant and therefore no subgroup analysis
could be performed.
Until now little research has been done in the area of information
needs of parents of long-term childhood cancer survivors.
Therefore, we found relatively few studies addressing information
needs of parents. Our findings about the domain and format of
information needs are in line with those reported in a semi-
structured telephone interview in Australia [8]. They reported that
parents had information needs especially on fertility and post-
treatment challenges and the desire to receive the information in a
written format, like an information booklet. Other studies assessed
needs in a broader way and found that information need was the
most prevalent unmet need [19,20].
In our study, we showed that most parents remember they
received some information, but that there is considerable room for
improvement. The majority of parents received verbal information,
Figure 1. Overview of parents reporting to have received information on illness, treatment, follow-up and late effects by format (verbal, written, no
information). Numbers do not add up to 100% because parents could indicate to have received both, verbal and written information. 95%
confidence interval, calculated for binomial distribution.
TABLE I. (Continued)
Participants Non-participantsa
N %c N %c P-valueb
Concerns about consequences of cancer
No concerns 51 27.4 n.a.
Medium concerns 55 29.4 n.a.
High concerns 81 43.3 n.a.
Participants Non-participantsa
Mean SD Mean SD P-valueg
Parent’s age 46.1 4.8 n.a.
Child’s age at study 14.7 1.8 15.0 1.9 0.223
Child’s age at diagnosis 3.4 2.2 3.6 2.4 0.573
Time since diagnosis 11.3 2.5 11.4 2.5 0.708
Percentages are based upon available data for each variable. CNS, central nervous system; LCH, Langerhans cell histiocytosis, SCT, stem cell
transplantation; n.a., not applicable. aNon-participants include: parents who did not respond (n ¼ 92), with unknown address (n ¼ 22) or who
refused to participate (n¼ 3) (Supplemental Figure 2). bP-value calculated from Chi-square statistics comparing parent participants and parent non-
participants. cColumn percentages are given. dInformation was not available from non-participants. eOther: malignant epithelial neoplasms,
malignant melanomas and other or unspecified malignant neoplasms. fChemotherapy may include surgery, radiotherapy may include
chemotherapy and/or surgery. gP-value calculated from paired t-test.
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a format that has its difficulties. It is good to get individual
explanations by the doctor and to clarify ambiguities. But the
information might be forgotten within a short time and not
remembered long after the cure of the child [21]. This might explain
the need of many parents to receive written general information in
addition to verbal information. However also having received
written information does not remove the need for additional
information at a later stage.
It is surprising that today only a minority of parents would like to
find more information on the internet. The cause might be the
unreliable and impersonal character of information provided online.
However, next to verbal and written information given by doctors
this will probably be the format chosen in the future because of its
accessibility, lower costs and broad availability. One study showed
that there is a paucity of high-quality internet information with
many sites lacking information on late effects [22]. Therefore,
professionals caring for survivors and their parents should develop
official online platforms with credible high quality health
information, supplying targeted, detailed and trustable information
regarding follow-up care and late effects.
We can assume that every parent receives information on illness
and specific treatment by the doctor. A large proportion of parents
reported never having received information on follow-up and
especially on late effects, and more than half of the parents reported
information needs in those two domains. This may be because at
the time of diagnosis this information was not considered of
importance or because parents really did not receive the information
by the health care provider. This might become a problem in the
future because every survivor and ideally also their parents should
be aware of potential late effects. For many, regular follow-up to
prevent, screen, detect and treat health care problems at an early
stage is of great importance. The unawareness both of survivors and
parents might partly explain the high number of patients being lost
to follow-up in adulthood [23].
Increased needs were reported by parents with a migration
background, with greater concerns about consequences of cancer
and by parents who did not receive all the information. Not
statistically significant but potentially relevant is a trend for higher
information needs among parents with higher education. It is
interesting that both parents with higher education and parents with
Figure 2. Proportion of parents who reported information needs versus no needs in the domains illness, treatment, follow-up and late effects.
Figure 3. Preferred format of information which parents with information needs would like to receive on illness, treatment, follow-up and late
effects. CI 95% confidence interval.
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TABLE II. Factors Associated With Information Needs in Parents (From Univariable Logistic Regression Models)
Information needs present Associations with information needs
N Total N (%)a OR 95%CI Global P
Sex 0.985
Female 151 113 74.8 1
Male 28 21 75.0 1.01 0.39–2.55
Age at study 0.477
 45 years 84 61 72.6 1
> 45 years 87 67 77.0 1.26 0.63–2.52
unknown 8 6 75.0 1.13 0.21–6.01
Migration background 0.039
Swiss 163 119 73.0 1
Immigrant 16 15 93.8 5.55 0.71–43.2
Language region 0.199
German 127 99 77.9 1
French 51 35 68.6 0.61 0.29– 1.27
Education 0.298
Primary 96 73 76.0 1
Secondary 59 41 69.5 0.71 0.35–1.48
Tertiary 21 18 85.7 1.89 0.51–6.99
Employment 0.648
Employed 143 106 74.1 1
Unemployed 36 28 77.8 0.54 0.51–2.92
Diagnosis 0.359
Leukemia/Lymphoma 84 59 70.2 1
CNS tumor 33 27 81.8 1.91 0.70–5.19
Other tumorb 62 48 77.4 1.45 0.68–3.10
Treatment receivedc 0.413
Surgery 28 19 67.9 1
Chemotherapy 112 82 73.2 1.29 0.53–3.17
Radiotherapy 28 24 85.7 1.92 0.76–10.67
SCT 9 7 77.8 1.49 0.29–9.64
Type of treating hospital 0.701
University hospital 152 113 74.3 1
Regional hospital 27 21 77.8 1.21 0.45–3.21
Child’s age at diagnosis 0.481
0–1 years 55 44 80.0 1
2–4 years 79 56 70.9 0.61 0.27–1.38
5þ years 45 34 75.6 0.77 0.30–1.90
Time since diagnosis 0.626
10þ years 118 87 73.7 1
< 10 years 61 47 77.0 1.19 0.58–2.47
Relapse 0.565
No 159 118 74.2 1
Yes 20 16 80.0 1.38 0.44–4.40
Parent-reported late effects 0.338
No 92 66 71.7 1
Yes 82 64 78.1 1.40 0.70–2.79
Parents involvement in follow-up care 0.089
No 38 24 63.2 1
Yes 136 105 77.2 1.98 0.91–4.27
Concerns about consequences of cancer 0.024
No concerns 48 29 60.4 1
Medium concerns 53 42 79.3 2.50 1.04–6.04
High concerns 77 63 81.8 2.95 1.30–6.68
Information receivedd 0.035
Yes 138 100 72.5 1
No 35 31 88.6 2.95 0.97–8.90
Percentages are based upon available data for each variable. CI, confidence interval; CNS, central nervous system; SCT, stem cell transplantation;
bold, P value lower than 0.05 aRow percentages are given. bOther: malignant epithelial neoplasms, malignant melanomas and other or unspecified
malignant neoplasms. cChemotherapy may include surgery, radiotherapy may include chemotherapy and/or surgery. dInformation received means
parents perception of information received.
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a migration background have more information needs [24]. Having
a higher education probably means being more likely to understand
and process the information and therefore try to seek additional
information. In contrast, parents with a migration background,
probably due to language difficulties or lack of familiarity with the
health system, might have larger problems in understanding the
information given and therefore report a higher information need.
Even though not statistically significant, our results suggest that
parents of children with a more severe disease (CNS tumor, relapse,
radiotherapy, late effects) may have a higher need for information.
The complexity of the disease together with often disabling late
effects might leave parents with many open questions. Information
provision to parents should be improved because of parents’ crucial
role in transferring this information to their children once they take
over responsibility for their own health. Only if information needs
are met and information is understood, will parents be able to point
out the importance of continued medical care and to prevent their
child from becoming lost to follow-up. Informed parents can also be
more active towards health care providers and this may help to
further motivate their child to adhere to follow-up and live a healthy
lifestyle. Additionally, information should be provided to survivors
themselves repeatedly during follow-up care in an age-adapted way.
Information to parents is not only important because of
knowledge transfer, but also to reassure themselves and to reduce
insecurity by giving adequate and consistent information
throughout, and long after treatment [4]. There remains an open
question about who should provide information, in which format
and at which time point [25]. Just because parents receive written
information on diagnosis does not necessarily mean they do not
have information needs many years later. Given the rapid increase
in the number of long-term survivors, health care providers are
progressively lacking resources to continue high quality follow-up
care for long-term survivors. We therefore suggest the use of a
survivorship passport including information about diagnosis,
treatment and expected late effects as well as a personal follow-up
care plan and information on health behaviors [26]. Such a
passport is currently being developed by the European ENCCA
project [27]. Another passport has been developed by the
Children’s Oncology Group and is already in use in many
institutions [28]. A summary of disease and treatment together
with an individualized survivorship care plan will help parents and
eventually survivors to get the needed information on their past
and future.
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